87 related articles for article (PubMed ID: 6194391)
1. [Predictive testing of cytostatics in ovarian cancer using Weisenthal's method].
Carstensen H
Lakartidningen; 1983 Jul; 80(30-31):2812-6. PubMed ID: 6194391
[No Abstract] [Full Text] [Related]
2. Cell viability assay for drug testing in ovarian cancer: in vitro kill versus clinical response.
Ness RB; Wisniewski SR; Eng H; Christopherson W
Anticancer Res; 2002; 22(2B):1145-9. PubMed ID: 12168915
[TBL] [Abstract][Full Text] [Related]
3. [Studies into dependence of sensitivity of cytostatics on overlap index of ovarian cancer in cell cultures (author's transl)].
Schindler C
Zentralbl Gynakol; 1982; 104(3):156-9. PubMed ID: 7043954
[TBL] [Abstract][Full Text] [Related]
4. Cell cultures and their use in drug sensitivity prediction.
Dendy PP; Mitchell JS; Dawson A; Williamson J
Arch Geschwulstforsch; 1981; 51(1):111-8. PubMed ID: 7259433
[TBL] [Abstract][Full Text] [Related]
5. [Resistance testing and chemotherapy results in animal and human tumors].
Volm M; Mattern J; Wayss K
Verh Dtsch Ges Pathol; 1978; 62():368. PubMed ID: 746886
[No Abstract] [Full Text] [Related]
6. Clinical correlations of in vitro drug sensitivity.
Salmon SE; Alberts DS; Meyskens FL; Durie BG; Jones SE; Soehnlen B; Young L; Chen HS; Moon TE
Prog Clin Biol Res; 1980; 48():223-45. PubMed ID: 7193872
[No Abstract] [Full Text] [Related]
7. [Attempt in determination of the sensitivity of ovarian neoplasms with ascites to cytostatics in tissue cultures].
Králová A
Cesk Gynekol; 1971 Sep; 36(7):437-8. PubMed ID: 5110668
[No Abstract] [Full Text] [Related]
8. Ovarian cancer biology.
Perez RP; Godwin AK; Hamilton TC; Ozols RF
Semin Oncol; 1991 Jun; 18(3):186-204. PubMed ID: 2042060
[No Abstract] [Full Text] [Related]
9. [Measurement of transmembrane potentials - a new method of in vitro tumor sensitivity testing].
Walliser S; Zipprich KW
Zentralbl Gynakol; 1984; 106(3):184-90. PubMed ID: 6702348
[TBL] [Abstract][Full Text] [Related]
10. [Chemosensitivity testing of topotecan as second-line agent in chemotherapy of ovarian cancer].
Qian XL; Peng ZL; Liu SL
Ai Zheng; 2003 Dec; 22(12):1352-4. PubMed ID: 14693068
[TBL] [Abstract][Full Text] [Related]
11. [Chemoresistance in ovarian cancer. State of the art and future prospects].
Katsaros D; Fracchioli S; Arese P; Enria R; Cassinelli P; Mingrone K; Piccinno R; Rigault de la Longrais IA; Massobrio M
Minerva Ginecol; 1999 Dec; 51(12):483-99. PubMed ID: 10767997
[TBL] [Abstract][Full Text] [Related]
12. [Chemosensitivity testing for human ovarian cancer on in vitro colony assay].
Inoue K
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1146-51. PubMed ID: 6471421
[TBL] [Abstract][Full Text] [Related]
13. [Effect of cytostatics on the ovarian neoplasms in the histological picture].
Vácha K; Kopecný J
Cesk Gynekol; 1971 Sep; 36(7):439-40. PubMed ID: 5110669
[No Abstract] [Full Text] [Related]
14. The behaviour of tumour cells of ovarian carcinomata under in vitro conditions and the coincidence with clinical controllability of tumours.
Krafft W; Brückmann D; Brückmann J; Preibsch W; Behling H; Kademann J
Arch Geschwulstforsch; 1981; 51(1):133-8. PubMed ID: 7259435
[TBL] [Abstract][Full Text] [Related]
15. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.
Orr JW; Orr P; Kern DH
Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175
[TBL] [Abstract][Full Text] [Related]
16. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.
Yahata H; Kobayashi H; Kamura T; Amada S; Hirakawa T; Kohno K; Kuwano M; Nakano H
J Cancer Res Clin Oncol; 2002 Nov; 128(11):621-6. PubMed ID: 12458343
[TBL] [Abstract][Full Text] [Related]
17. [In vitro resistance testing of tumors in relation to cytostatics. 2. Examinations with human malignomas].
Possinger K; Hartenstein R; Ehrhart H
Onkologie; 1980 Dec; 3(6):297-300. PubMed ID: 7012727
[TBL] [Abstract][Full Text] [Related]
18. Update on in vitro testing on new drugs in ovarian cancer and melanoma.
Salmon SE; Meyskens FL; Alberts DS; Soehnlen B; Young L
Cancer Treat Rep; 1981; 65(5-6):532-3. PubMed ID: 7195308
[No Abstract] [Full Text] [Related]
19. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
20. [Treatment for recurrent ovarian cancer].
Hasegawa K; Torii H; Ooe S; Udagawa Y
Gan To Kagaku Ryoho; 2009 Feb; 36(2):230-6. PubMed ID: 19263612
[No Abstract] [Full Text] [Related]
[Next] [New Search]
